Aurantimycin A

CHF 95.00
In stock
BVT-0398-M0011 mgCHF 95.00
More Information
Product Details
Product Type Chemical


MW 857.0
CAS 162478-50-4
Source/Host Chemicals Isolated from Streptomyces aurantiacus JA 4570.
Purity Chemicals ≥98% (HPLC)
Appearance Off-white solid.
Solubility Soluble in chloroform, dichloromethane or DMSO. Poorly soluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by BioViotica.
Smiles [H][C@@]12CCCNN1C(=O)CNC(=O)[C@H](COC)N(O)C(=O)[C@@]1([H])CCCNN1C(=O)[C@@H](NC(=O)[C@](C)(O)[C@]1(O)CC[C@@H](CC(C)C)[C@H](C)O1)[C@@H](OC(=O)[C@@H](C)N(O)C2=O)C(C)C
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep cool and dry.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
After reconstitution protect from light at -20°C.
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Depsipeptide antibiotic.
  • Active against Gram-positive bacteria.
  • Cytotoxic agent.
  • Nematocide activity.
  • Antiulcer agent.
  • Anti-inflammatory drug (C5a antagonist).
Product References
  1. Aurantimycins, new depsipeptide antibiotics from Streptomyces aurantiacus IMET 43917: U. Graefe, et al.; J. Antibiot. 48, 119 (1995)
  2. Formation of membrane pores by aurantimycins A and B, new lipopeptide antibiotics from Streptomyces aurantiacus: P. Grigoriev, et al.; Bioelectrochem. Bioenerget. 36, 57 (1995)
  3. Pharmacological actions of a new synthetic cyclodepsipeptide, the A83586C-citropeptin hybrid, on complement C5a and G-proteins: E.-S. K. Assem, et al.; Inflamm. Res. 57, 21 (2008)
  4. Aurantimycin resistance genes contribute to survival of Listeria monocytogenes during life in the environment: S. Hauf, et al.; Mol. Microbiol. 111, 1009 (2019)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.